Immunogenics and Flow Cytometry
免疫原学和流式细胞术
基本信息
- 批准号:10089827
- 负责人:
- 金额:$ 31.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-06-01 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:Animal Cancer ModelB cell repertoireB-cell receptor repertoire sequencingBig DataBloodBlood CellsBudgetsCancer Center Support GrantCellsClinicalClinical InvestigatorClinical ResearchCollaborationsCommunitiesComplementComputer softwareCoupledCytokine Network PathwayCytometryDNA sequencingDataData AnalysesData SetDoctor of PhilosophyElementsEquipmentEvaluationExonsExperimental DesignsFacultyFlow CytometryFlow Cytometry Shared ResourceGenomicsGoalsHaplotypesHumanHybridsImmuneImmune responseImmunogenomicsImmunologic MonitoringInfrastructureInvestmentsKnowledgeMalignant NeoplasmsMass Spectrum AnalysisMethodologyMissionModelingMusPathway AnalysisPatientsPhenotypePlasmaRecording of previous eventsReportingReproducibilityResearchResearch DesignResearch PersonnelResource SharingRunningSamplingScienceServicesSorting - Cell MovementSourceStudentsSystemT-LymphocyteTechniquesTechnologyTimeTissuesTrainingTumor-infiltrating immune cellsWorkanticancer researchcomputing resourcescostdata acquisitionexomeexperienceexperimental studygenetic signatureimmunogenicimmunotherapy trialsin vivoinnovative technologiesinterestmemberneoantigensnew technologynext generation sequencingpeerpre-clinicalprogramsresponsesingle cell analysissingle-cell RNA sequencingtumor
项目摘要
ABSTRACT: IMMUNOGEONOMICS AND FLOW CYTOMETRY SHARED RESOURCE
The Immunogenomics and Flow Cytometry SR (IMCF) is a hybrid core that provides access to state-of-the-art
techniques such as mass cytometry and immunogenomics analysis of bulk and single cell next generation
sequencing data coupled with a high utilization Flow Cytometry facility with a 30-year LCCC history. New
immune monitoring capabilities were developed in response to investigator needs, particularly for the analysis
of immune responses in preclinical tumor models and human clinical research. The immunogenomics
component offers a full suite of immunogenomics techniques, including immune gene signature and pathway
analysis, cell phenotype deconvolution, MHC haplotype prediction, neoantigen prediction, T cell and B cell
repertoire profiling, and systems level analyses such as cytokine network analysis and integrated survival
modeling. This is joined by an investment in CyTOF for expanded panel analysis of cellular phenotypes. This
component currently supports correlative science for tissues being collected from eight immunotherapy trials
and multiple in vivo animal models of cancer. In addition to these new capabilities, the facility also houses a full
complement of highly used analytic flow cytometers and cell sorters for both mouse and human work, New
purchases in addition the CyTOF are two new spectral analytic machines. Most important for the research
community, all SR components have expert staff to support investigators in experimental design, sample
processing, data acquisition, and downstream analysis. IMCF is led by Dr. Vincent, MD, an expert in
immunogenomics and Dr. Fisher, PhD who has led the LCC Flow facility since 2010 and has over 30 years’
experience in flow cytometry. The budget requested ($211,126) is a small proportion of the total operating
budget of $1.7M. Flow cytometry is a traditionally heavily used facility; 80 members were users in fiscal year
2019.
摘要:免疫地理学和流式细胞术共享资源
免疫基因组学和流式细胞术SR(IMCF)是一种混合核心,可提供最先进的
下一代大细胞和单细胞的大量细胞计数和免疫基因组学分析等技术
测序数据加上具有30年LCCC历史的高利用率流式细胞仪设施。新
免疫监测能力的发展是为了满足研究者的需要,特别是分析
临床前肿瘤模型和人类临床研究中的免疫应答。免疫基因组学
组件提供了一整套免疫基因组学技术,包括免疫基因签名和途径
分析、细胞表型解卷积、MHC单体型预测、新抗原预测、T细胞和B细胞
库分析和系统水平分析,如细胞因子网络分析和整合存活
建模此外,还投资于CyTOF,用于细胞表型的扩展面板分析。这
该组件目前支持从八项免疫治疗试验中收集的组织的相关科学
和多种癌症的体内动物模型。除了这些新功能外,该设施还拥有一个完整的
补充高度使用的分析流式细胞仪和细胞分选仪,用于小鼠和人类工作,新
购买除了CyTOF是两个新的光谱分析机器。对研究来说最重要的
社区,所有SR组件都有专家工作人员,以支持研究人员在实验设计,样品
处理、数据采集和下游分析。IMCF由医学博士Vincent领导,他是
Fisher博士自2010年以来一直领导LCC Flow设施,拥有超过30年的
有流式细胞术经验。请拨的预算(211 126美元)只占业务费用总额的一小部分。
预算170万元。流式细胞仪是一种传统上使用量很大的设施;在本财政年度有80名成员是用户
2019.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin G Vincent其他文献
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30sup+/sup lymphoma: a phase 1 study
抗 CD30 CAR T 细胞作为高危 CD30⁺/⁺淋巴瘤患者自体造血干细胞移植后的巩固治疗:一项 1 期研究
- DOI:
10.1016/s2352-3026(24)00064-4 - 发表时间:
2024-05-01 - 期刊:
- 影响因子:17.700
- 作者:
Natalie S Grover;George Hucks;Marcie L Riches;Anastasia Ivanova;Dominic T Moore;Thomas C Shea;Mary Beth Seegars;Paul M Armistead;Kimberly A Kasow;Anne W Beaven;Christopher Dittus;James M Coghill;Katarzyna J Jamieson;Benjamin G Vincent;William A Wood;Catherine Cheng;Julia Kaitlin Morrison;John West;Tammy Cavallo;Gianpietro Dotti;Barbara Savoldo - 通讯作者:
Barbara Savoldo
Benjamin G Vincent的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin G Vincent', 18)}}的其他基金
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
Gvl mHA 特异性 T 细胞反应可预防同种异体干细胞移植后 AML 复发
- 批准号:
10652626 - 财政年份:2020
- 资助金额:
$ 31.47万 - 项目类别:
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
Gvl mHA 特异性 T 细胞反应可预防同种异体干细胞移植后 AML 复发
- 批准号:
10436256 - 财政年份:2020
- 资助金额:
$ 31.47万 - 项目类别:
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
Gvl mHA 特异性 T 细胞反应可预防同种异体干细胞移植后 AML 复发
- 批准号:
10202516 - 财政年份:2020
- 资助金额:
$ 31.47万 - 项目类别:
相似海外基金
High-resolution deconvolution of selection effects on the composition of the B cell repertoire
选择对 B 细胞库组成的影响的高分辨率反卷积
- 批准号:
9980447 - 财政年份:2019
- 资助金额:
$ 31.47万 - 项目类别:
High-resolution deconvolution of selection effects on the composition of the B cell repertoire
选择对 B 细胞库组成的影响的高分辨率反卷积
- 批准号:
10224256 - 财政年份:2019
- 资助金额:
$ 31.47万 - 项目类别:
High-resolution deconvolution of selection effects on the composition of the B cell repertoire
选择对 B 细胞库组成的影响的高分辨率反卷积
- 批准号:
10470156 - 财政年份:2019
- 资助金额:
$ 31.47万 - 项目类别:
High-resolution deconvolution of selection effects on the composition of the B cell repertoire
选择对 B 细胞库组成的影响的高分辨率反卷积
- 批准号:
10671016 - 财政年份:2019
- 资助金额:
$ 31.47万 - 项目类别:
Investigating B-cell repertoire data using deep learning approaches to aid in the development of antibody therapeutics
使用深度学习方法研究 B 细胞库数据以帮助开发抗体疗法
- 批准号:
2271214 - 财政年份:2019
- 资助金额:
$ 31.47万 - 项目类别:
Studentship
Factors that influence the avian T and B cell repertoire
影响禽类 T 和 B 细胞库的因素
- 批准号:
2107535 - 财政年份:2018
- 资助金额:
$ 31.47万 - 项目类别:
Studentship
The B cell repertoire as a window into the nature and impact of the lung virome
B 细胞库是了解肺病毒组性质和影响的窗口
- 批准号:
10165793 - 财政年份:2017
- 资助金额:
$ 31.47万 - 项目类别:
Development of a new rheumatoid arthritis monitoring method by analysis of anti-CCP antibody-producing B cell repertoire
通过分析产生抗 CCP 抗体的 B 细胞库开发新的类风湿性关节炎监测方法
- 批准号:
17K08973 - 财政年份:2017
- 资助金额:
$ 31.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Demographics Causes and Consequences of B Cell Repertoire Diversity
B 细胞库多样性的人口统计学原因和后果
- 批准号:
9199843 - 财政年份:2015
- 资助金额:
$ 31.47万 - 项目类别:
Demographics Causes and Consequences of B Cell Repertoire Diversity
B 细胞库多样性的人口统计学原因和后果
- 批准号:
8991476 - 财政年份:2015
- 资助金额:
$ 31.47万 - 项目类别: